Lilly anunta rezultatele financiare aferente trimestrului al doilea din 2026

publicat 2026-08-05 19:00:43 (Bursa)
*Veniturile din T2 2026 au crescut cu 48%, pana la 23,0 miliarde USD si au fost generate in principal de tratamentele GLP-1 *In T2, profitul per actiune a crescut cu 26%, pana la 7,94 USD pe baza raportata, si cu 33%, pana la 8,38 USD pe baza non-GAAP *In T2 2026, au fost finalizate achizitiile Orna Therapeutics, Inc., Ajax Therapeutics, Inc., Centessa PHARMACeuticals plc si Kelonia Therapeutics, Inc. Dupa incheierea trimestrului, compania a finalizat... ...continuare.

European Commission refers Romania to the CJEU over late payments to PHARMACies

publicat 2026-07-08 14:15:10 (Mediafax)
The European Commission decided on Wednesday to refer Romania to the Court of Justice of the European Union (CJEU), accusing the Romanian state of failing to ensure timely payment to PHARMACies, thus violating the European Directive on combating late payments. ...continuare.

Emergency Medicine in Romania, between Systemic Fragmentation and the Pressure of Technology

publicat 2026-06-08 00:00:05 (Bursa)
The Romanian medical system continues to function with a 'hiatus' between emergency medicine and the rest of the healthcare structure, said the rector of the 'George Emil Palade' University of Medicine, PHARMACy, Sciences and Technology in Targu Mures, Leonard Azamfirei, at the National Congress of Emergency Medicine and Disaster Medicine (CongrEMs 2026). ...continuare.
EMAG
pharmac mares opinia timisoarei plan r rtega casa de sondaj gen i i dent baloane eram league 2 el simio pelerinaj idef el w pressu albacete israel exert dedicatii corneliu baba slab systematic horoscop 15 august s is more aloe vera malaysia airlines the wh casier la bunica acasa el he motocicleta naturiste pope leo xiv cipru he j aventura field o e cente eficienta urgent silvia chifiriuc la sñ cerut o id o europarlamentari le la pe bangara en ro ice fo



© Copyright 2000-2026 iStorm. Toate drepturile rezervate.